Institutional Ownership
Aravive Inc
CUSIP 03890D108Common / Ordinary StockVSAREURQ1 2026
13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
43.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
19 filings · latest Feb 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2024 | Baker Bros. Advisors LP | 13G/A | 5.0% | 3.86M | SEC |
| 2 | Feb 14, 2024 | Biotechnology Value Fund L P | 13G/A | 7.1% | 5.66M | SEC |
| 3 | Feb 9, 2024 | Artal International S.C.A. | 13G/A | 9.4% | 7.61M | SEC |
| 4 | Feb 14, 2023 | Baker Bros. Advisors LP | 13G | 7.5% | 4.59M | SEC |
| 5 | Feb 13, 2023 | Artal International S.C.A. | 13G/A | 9.9% | 12.18M | SEC |
| 6 | Dec 28, 2022 | Zhang Eric | 13D/A | 3.4% | 2.03M | SEC |
| 7 | Dec 27, 2022 | Giaccia Amato | 13D/A | 2.9% | 1.73M | SEC |
| 8 | Nov 7, 2022 | Biotechnology Value Fund L P | 13G | 6.4% | 3.91M | SEC |
| 9 | Nov 3, 2022 | Eshelman Ventures, LLC | 13D/A | 43.5% | 26.38M | SEC |
| 10 | Apr 5, 2022 | Eshelman Fredric N | 13D/A | 33.9% | 10.07M | SEC |
9 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aravive Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Massmutual Private Wealth & Trust, Fsb | 9.3K | $373 |